Win-Win: CVS & Target Make a Deal

MarketFoolery

The Motley Fool

Money, Business, Motley, Business News, Stocks, News, Investing, Market, Fool

4.7 • 1.7K Ratings

🗓️ 15 June 2015

⏱️ 18 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

CVS Health buys Target’s pharmacy & clinic businesses for $1.9 billion. We discuss why it’s a win for both companies and anaylze why Leapfrog may be on its last legs. Plus we share highlights from our event in Seattle, including the wisdom of Costco’s Jim Sinegal.

Transcript

Click on a timestamp to play from that location

0:00.0	It's Monday, June 15th.
0:03.3	Welcome to Market Fullry.
0:04.4	I'm Chris Hill joining me in studio today for Motley Fool Deep Value, Ron Gross.
0:08.2	Hey, hey, happy Monday.
0:09.9	Happy Monday.
0:10.6	Good weekend?
0:11.8	Good weekend? Good weekend?
0:13.0	Warm here, boy.
0:14.0	You are out in the land of...
0:16.0	I was going to say, you know what the weather like?
0:17.0	It was like in Seattle?
0:18.0	It was amazing.
0:19.0	And it's probably the only week this year it was going to be amazing.
0:22.0	But yeah, it was brutal over be amazing but yeah we were at
0:24.7	the some of us are at the Motley Full One event in Seattle I'll talk a little bit
0:28.1	about that later on but let's start with the big news of the day.
0:33.0	CVS Health is buying the pharmacy and clinic businesses from Target for 1.9 billion dollars,
0:41.0	more than 1,600 locations across the country.
0:44.2	Now when you go into Target to get your prescription filled,
0:47.4	it's gonna be a store within a store.
0:48.9	It's gonna be rebranded, CVS Health. Plus the clinics, there's about 80 clinics, then there will be more.
0:55.0	It will be relabeled the Minute Clinic.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from The Motley Fool, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of The Motley Fool and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.